[AMDA] Amedica Corporation

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 0.65 Change: -0.01 (-1.52%)
Ext. hours: Change: 0 (0%)

chart AMDA

Refresh chart

Strongest Trends Summary For AMDA

AMDA is in the medium-term down -30% in 4 months. In the long-term down -96% in 2 years and down -100% in 7 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Amedica Corporation, a commercial-stage biomaterial company, develops, manufactures, and sells a range of medical devices in the United States. It offers Valeo silicon nitride interbody spinal fusion devices for use in the cervical and thoracolumbar areas of the spine; Valeo stand-alone anterior lumbar intervertebral fusion device; and a line of non-silicon nitride spinal fusion products used by surgeons to promote bone growth and fusion in spinal fusion procedures. The company also develops femoral heads for use in its total hip replacements; and femoral condyle components for use in its total knee replacements. It markets and sells its products to surgeons and hospitals in the United States, Europe, and South America through a network of independent sales distributors. The company has research and development agreement with Kyocera Industrial Ceramics Corporation to manufacture silicon nitride-based spinal fusion products and product candidates. Amedica Corporation was founded in 1996 and is headquartered i

Fundamental Ratios
Shares Outstanding EPS-1.43 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -18.73% Sales Growth - Q/Q-7.92% P/E-0.22
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-76.16% ROE-1045.27% ROI-169.04%
Current Ratio1.28 Quick Ratio0.81 Long Term Debt/Equity2.47 Debt Ratio7.38
Gross Margin64.18% Operating Margin-111% Net Profit Margin-153.03% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-120 K Cash From Investing Activities-270 K Cash From Operating Activities-2.97 M Gross Profit3.22 M
Net Profit-5.38 M Operating Profit-4.1 M Total Assets43.66 M Total Current Assets30.11 M
Total Current Liabilities23.49 M Total Debt22.27 M Total Liabilities40.48 M Total Revenue4.74 M
Technical Data
High 52 week3.13 Low 52 week0.17 Last close0.2 Last change-4.67%
RSI55.81 Average true range0.03 Beta0.12 Volume212.16 K
Simple moving average 20 days-3.05% Simple moving average 50 days-14.22% Simple moving average 200 days-35.05%
Performance Data
Performance Week-9% Performance Month-12.99% Performance Quart-4.67% Performance Half-47.95%
Performance Year-86.46% Performance Year-to-date11.22% Volatility daily3.88% Volatility weekly8.67%
Volatility monthly17.78% Volatility yearly61.58% Relative Volume268.27% Average Volume283.16 K
New High New Low

News

2019-01-03 09:00:00 | SINTX ANNOUNCES 30-YEAR SPINE FUSION DATA WITH SILICON NITRIDE IMPLANTS

2018-10-31 09:00:00 | AMEDICA ANNOUNCES CORPORATE NAME CHANGE TO SINTX TECHNOLOGIES, INC.

2018-10-03 09:00:00 | AMEDICA ANNOUNCES CLOSING OF THE SALE OF ITS SPINE BUSINESS TO CTL MEDICAL

2018-09-26 08:10:00 | Amedica Agrees to Sell its Commercial Spine Products Business, Analyst Coverage

2018-09-25 08:00:34 | DFW company makes key acquisition that started with a cold call

2018-09-11 09:00:00 | Amedica Corporation to Host Conference Call to Discuss Recent Sale of Spine Implant Business and Transition to Biomaterials Company

2018-09-10 09:00:00 | AMEDICA ANNOUNCES FILING OF KEY PATENT APPLICATION RELATING TO THE ANTI-VIRAL EFFECT OF ITS SILICON NITRIDE

2018-09-06 09:00:00 | AMEDICA ANNOUNCES AGREEMENT TO SELL SPINE BUSINESS TO CTL MEDICAL

2018-08-21 09:00:00 | Amedica Announces Successful Completion of First Valeo® C+CSC with Lumen Interbody Fusion Surgery

2018-07-24 07:45:00 | Complimentary Technical Snapshots on PAVmed and Three More Medical Equipment Stocks

2018-06-27 07:10:00 | Initiating Free Research Reports on Avinger and Three Other Medical Equipment Equities

2018-06-04 15:06:20 | How Financially Strong Is Amedica Corporation NASDAQ:AMDA?

2018-05-24 07:05:00 | Abbott Labs and Three Additional Medical Equipment Stocks on Our Research Desk’s Radar

2018-05-14 16:26:16 | Amedica Corporation Announces Closing of $15,000,000 Public Offering of Units Consisting of Convertible Preferred Stock and Warrants

2018-05-10 09:20:00 | Amedica Corporation Announces Pricing of $15,000,000 Public Offering of Units Consisting of Convertible Preferred Stock and Warrants

2018-05-09 08:20:00 | Today’s Research Reports on Stocks to Watch: Amedica Corporation and Aralez Pharmaceuticals

2018-05-08 09:30:00 | Amedica Corporation Provides Update on its Clinical Studies

2018-04-10 11:43:17 | What Should You Know About Amedica Corporation’s NASDAQ:AMDA Growth?

2018-03-30 09:00:00 | Amedica Announces Patent Grant for Silicon Nitride and Other Ceramic Materials

2018-03-26 16:58:15 | Does Amedica Corporation’s NASDAQ:AMDA Latest Financial Perfomance Look Strong?

2018-03-15 09:00:00 | Amedica Granted Extension by NASDAQ to Regain Compliance with NASDAQ Listing Rule

2018-03-06 09:29:18 | Amedica's stock rockets off record low after FDA clearance of spinal fusion implant device

2018-03-06 09:00:00 | Amedica announces FDA Clearance of the Valeo C+CSC with Lumen Interbody Fusion Device

2018-02-27 09:00:00 | AMEDICA Announces Participation in Australian Spine Conference

2018-01-25 09:00:00 | AMEDICA PROVIDES BUSINESS UPDATE

2017-12-15 12:51:01 | ETFs with exposure to Amedica Corp. : December 15, 2017

2017-12-05 12:17:54 | ETFs with exposure to Amedica Corp. : December 5, 2017

2017-12-01 09:00:00 | Amedica Receives Positive Nasdaq Listing Decision

2017-12-01 08:10:37 | Amedica Corp. :AMDA-US: Earnings Analysis: Q3, 2017 By the Numbers : December 1, 2017

2017-11-28 07:50:00 | Blog Exposure - Hologic Gets FDA Clearance for QuantraTM 2.2 Breast Density Assessment Software

2017-11-21 07:59:11 | Breaking Down Amedica Corporation’s AMDA Ownership Structure

2017-11-21 06:50:00 | Amedica Corp. to Host Earnings Call

2017-11-15 09:00:00 | Amedica Corporation to Review Third Quarter 2017 Financial Results and Host Conference Call

2017-11-15 07:57:07 | Does Amedica Corporation’s AMDA Debt Level Pose A Serious Problem?

2017-11-10 09:00:00 | Amedica Announces Reverse Stock Split

2017-11-06 09:00:00 | Amedica Submits 510k Application to FDA for Valeo C+CSC with Lumen

2017-10-23 09:00:00 | Amedica Announces Podium Presentations and Participation at NASS 2017

2017-10-17 09:00:00 | Amedica Receives Positive Nasdaq Listing Decision

2017-10-03 10:25:56 | Amedica Announces Adjournment of Special Meeting of Stockholders

2017-09-27 09:00:00 | Amedica Announces Adjournment of Special Meeting of Stockholders

2017-09-22 09:00:00 | Amedica Releases First and Second Quarter 2017 Preliminary Unaudited Earnings Report and Business Update

2017-09-07 09:00:00 | Amedica Announces Adjournment of Special Meeting of Stockholders

2017-08-25 17:00:00 | Amedica Receives Nasdaq Listing Determination; Plans to Request Hearing

2017-08-14 16:30:00 | Amedica Announces Adjournment of Special Meeting of Stockholders

2017-06-22 09:00:00 | Is Amedica a Value Proposition at These Levels?

2017-06-09 09:00:00 | CORRECTION - Amedica Releases 2016 Preliminary Unaudited Earnings Report and Business Update

2017-06-08 09:00:00 | Amedica Releases 2016 Preliminary Earnings Report and Business Update

2017-05-26 09:00:00 | Amedica Announces Delayed Filing of Quarterly Report on Form 10-Q and Receipt of Nasdaq Letter

2017-04-24 07:00:00 | Amedica Announces Regulatory Clearance to Market and Sell ValeoR Silicon Nitride Spinal Implants in Australia

2017-04-19 07:00:00 | Amedica Announces Delayed Filing of Annual Report on Form 10-K and Receipt of Nasdaq Letter